Very effect Excellent service
Benefits and Risks of Semaglutide Semaglutide is recognized for its efficacy in promoting weight loss
The 2025 narrative review noted that despite the volume of preclinical work, well-controlled human trial data are scarce, and the regenerative findings should be interpreted accordingly (PMID 40789979)
Aim for 150-300 minutes of moderate-intensity aerobic activity each week
NHS England rolled out tirzepatide for weight management in cohorts after NICE TA1026 in December 2024: 3 Cohort 1 (from June 2025): adults with a body mass index (BMI) of 40 or higher and at least four of five weight-related conditions (type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease)
Body composition Two people of the same weight, height, sex, and age can have different metabolic rates if their muscle-to-fat ratio differs